| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/02/2006 | US20060025410 2,4-Pyrimidinediamine compounds and their uses |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060022584 Red organic ligh-emitting compound and organic light-emitting device comprising the same |
| 02/02/2006 | US20060022193 As sensitizers, optical brighteners and electroluminescent materials; monomers for the synthesis of polymeric light emitting materials of electroluminescent elements |
| 02/02/2006 | CA2575359A1 Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 02/02/2006 | CA2574608A1 Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | CA2574361A1 1, 3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists |
| 02/02/2006 | CA2574305A1 1, 1a, 5, 5a-tetrahydro-s-thia-cyclopropa'a! pentalenes: tricyclic thiophene derivatives as s1p1/edg1 receptor agonists |
| 02/02/2006 | CA2572970A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/02/2006 | CA2572833A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 02/02/2006 | CA2571668A1 4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compositions containing same |
| 02/02/2006 | CA2571587A1 Quaternary salt ccr2 antagonists |
| 02/02/2006 | CA2571223A1 Quinazoline derivatives |
| 02/01/2006 | EP1621535A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/01/2006 | EP1621195A2 The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 02/01/2006 | EP1620432A1 Nk-2 antagonist basic linear compounds and formulations containing them |
| 02/01/2006 | EP1620431A1 3-carbonylaminothiophenes and their use as fungicides |
| 02/01/2006 | EP1620429A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | EP1620411A2 Inhibitors of akt activity |
| 02/01/2006 | EP1620410A1 Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 02/01/2006 | EP1620402A1 Cyclic quaternary amino derivatives as modulators of chemokine receptors |
| 02/01/2006 | EP1620400A1 Chemical compounds |
| 02/01/2006 | EP1620395A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
| 02/01/2006 | EP1620110A2 Immunomodulator phosphonate conjugates |
| 02/01/2006 | EP1620082A2 Medical use of inhibitors of glutaminyl and glutamate cyclases |
| 02/01/2006 | EP1370548B1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same |
| 02/01/2006 | EP1119563B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 02/01/2006 | EP0970057B1 Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof |
| 02/01/2006 | CN1729181A Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | CN1729176A Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 02/01/2006 | CN1729175A Tetrahydroquinoline derivatives |
| 02/01/2006 | CN1729174A Synthesis of amines and intermediates for the synthesis thereof |
| 02/01/2006 | CN1729171A Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/01/2006 | CN1728999A Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/01/2006 | CN1239499C Episulfide compound, its producing process and optical products containing the same |
| 01/31/2006 | US6992104 C7 carbonate taxane compositions |
| 01/31/2006 | US6992101 indole and thieno (2,3-B)pyrrole compounds with 1,1-dioxo tetrahydro thiophene or pyran ring; treating diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, hypertension, hyperinsulinemia, hyperlipidemia, ischemia |
| 01/31/2006 | US6992097 such as methyl-1-{2-[4-((2R)-2-{2-[(tert-butoxy)carbonylamino]-2-methylpropanoylamino}-3-indol-3-ylpropanoylamino)imidazolyl]-2-phenylacetyl}pyrrolidine-2-carboxylate |
| 01/31/2006 | US6992094 selenium nicotinic acid tetrahyronaphthaline compounds; treating skin disorders |
| 01/31/2006 | US6992087 Substituted aryl 1,4-pyrazine derivatives |
| 01/31/2006 | US6991857 Metal coordination compound, luminescence device and display apparatus |
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/31/2006 | CA2224635C Pyridine derivatives, process for preparing the same, and intermediate therefor |
| 01/31/2006 | CA2119261C Novel sidechain-bearing taxanes and intermediates thereof |
| 01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | WO2006010094A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| 01/26/2006 | WO2006008259A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 01/26/2006 | WO2005116009B1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors |
| 01/26/2006 | WO2005085234A3 Bycyclic anthranilamide derivatives useful as insecticides |
| 01/26/2006 | WO2005077922A3 Process for the preparation of substituted triazole compounds |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020039 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-fluorophenoxy)1-aminoisoquinoline; and 3-(2-(4-[(2-aminosulfonyl)phenyl]phenylaminocarbonyl-4-chlorophenoxy)benzamidine; highly selective |
| 01/26/2006 | US20060020011 Diseases mediated by tachykinins and for seritonin reuptake transporter protein as reuptake inhibitors |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/26/2006 | US20060019995 2,3-dihydro-4(1H)-pyridone derivatives , method for production thereof and pharmaceutical composition comprising the same |
| 01/26/2006 | US20060019974 4-Amino-quinazolines |
| 01/26/2006 | US20060019973 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 01/26/2006 | US20060019831 1-(3-trifluoromethyl)phenyl-3-(N-methyl)carboxamido-2-pyrrolidinone; herbicides; high compatibility with crop plants is desirable; no adverse effect on the chlorophyll synthesis in crop plants; crop protection compositions |
| 01/26/2006 | CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 01/26/2006 | CA2573210A1 Viral polymerase inhibitors |
| 01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | CA2572821A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitable for the treatment of neurodegenerative disorders |
| 01/26/2006 | CA2572775A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| 01/26/2006 | CA2570968A1 Gonadotropin releasing hormone receptor antagonists |
| 01/25/2006 | EP1618105A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
| 01/25/2006 | EP1618094A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 01/25/2006 | EP1618093A2 Indazole derivatives as jnk inhibitors |
| 01/25/2006 | EP1617848A2 Anti-cancer phosphonate conjugates |
| 01/25/2006 | CN1726603A Charge transport compositions and electronic devices made with such compositions |
| 01/25/2006 | CN1726211A Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 01/25/2006 | CN1726210A Novel compounds having selective inhibiting effect at GSK3 |
| 01/25/2006 | CN1726209A 3-substituted-4-pyrimidone derivatives |
| 01/25/2006 | CN1726207A Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 01/25/2006 | CN1726206A Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 01/25/2006 | CN1726205A 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 01/25/2006 | CN1726204A Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 01/25/2006 | CN1726190A Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 01/25/2006 | CN1726042A Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 01/25/2006 | CN1238343C Pyrimidine derivatives and herbicides containing the same |
| 01/24/2006 | US6989398 Benzanilides as potassium channel openers |
| 01/24/2006 | US6989397 Iron chelators and uses thereof |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989392 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989379 Selective NPY (Y5) antagonists |
| 01/24/2006 | US6989264 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 01/24/2006 | CA2205757C Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii) |
| 01/24/2006 | CA2123093C Sulfonamide herbicides |
| 01/19/2006 | WO2006005955A1 Amide derivatives as inhibitors of histone deacetylase |
| 01/19/2006 | WO2006005915A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2006005914A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2005113514A3 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems |
| 01/19/2006 | WO2005097746A3 2-propene-1-ones as hsp 70 inducers |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | WO2005075458A8 Pyrimidine derivatives as orexin receptors antagonists |